Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director's Dealings

8 Jun 2016 10:57

RNS Number : 5972A
Premier Veterinary Group PLC
08 June 2016
 

PREMIER VETERINARY GROUP PLC

 

Director's Dealings

 

London, UK, 8 June 2016 (LSE: PVG): Premier Veterinary Group plc ("the Company") has received notification that on 7 June 2016 Rajan Uppal, a Director of the Company, 

transferred 6,900,000 ordinary shares of 10 pence each in the Company previously held in the name of Lynchwood Nominees Limited to another nominee account Vidacos Nominees Limited. 

 

In addition Mr Uppal has notified the company that on 7 June 2016 he sold on a matched bargain basis 580,000 ordinary shares of 10 pence each in the Company from his nominee account held by Vidacos Nominees Limited. The shares were purchased by Mr Uppal's

Self-invested Personal Pension and are also held in the name of Vidacos Nominees Limited. The sale was made at 142.5 pence per ordinary share. 

 

Following these transactions, there has been no change to the total beneficial holding of Mr Uppal, and he continues to be interested in 7,035,887 ordinary shares (which represents approximately 50.43% of the Company's issued share capital) as follows:

 

Rajan Uppal 6,383,387

Rajan Uppal individual savings account 60,000

Rajan Uppal self-invested personal pension 580,000

Tracey Uppal individual savings account 12,500

 

 

The Company's issued share capital as at the date of this notification is 13,951,773 ordinary shares of 10 pence each.

 

 

For further information please contact:

 

Premier Veterinary Group plc  Tel:  +44(0)117 970 4127

 

Sue Steven, Company Secretary

Daniel Smith, Chief Financial Officer

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHKMGGVLRKGVZG
Date   Source Headline
10th Mar 20101:21 pmRNSEPT Disclosure
10th Mar 201011:52 amRNSEPT Disclosure
10th Mar 20107:00 amRNSFinal Results
9th Mar 20107:00 amRNSResearch Update
8th Mar 20105:34 pmRNSHolding(s) in Company
23rd Feb 20107:00 amRNSResearch Update
19th Feb 20107:00 amRNSRe Agreement
16th Feb 20104:40 pmRNSSecond Price Monitoring Extn
16th Feb 20104:35 pmRNSPrice Monitoring Extension
11th Feb 201011:37 amRNSDirector/PDMR Shareholding
5th Feb 20104:35 pmRNSPrice Monitoring Extension
29th Jan 20103:23 pmRNSTotal Voting Rights
28th Jan 201011:05 amRNSNotice of Results
28th Jan 20107:02 amRNSResearch Update
28th Jan 20107:00 amRNSResearch Update
20th Jan 20103:51 pmRNSEmployee Benefit Trust
5th Jan 20107:00 amRNSArk files for re-examination of Cerepro
22nd Dec 20094:41 pmRNSSecond Price Monitoring Extn
22nd Dec 20094:35 pmRNSPrice Monitoring Extension
18th Dec 200911:56 amRNSEMEA recommendation on Cerepro
15th Dec 20092:29 pmRNSHolding(s) in Company
3rd Dec 20092:41 pmRNSBlocklisting Interim Review
3rd Dec 20092:35 pmRNSHolding(s) in Company
24th Nov 20094:04 pmRNSHolding(s) in Company
11th Nov 20097:00 amRNSInterim Management Statement
14th Oct 20097:00 amRNSResearch Update
2nd Oct 200911:04 amRNSHolding(s) in Company
30th Sep 200910:51 amRNSHolding(s) in Company
29th Sep 20094:32 pmRNSHolding(s) in Company
4th Sep 20097:00 amRNSResearch Update
1st Sep 200912:08 pmRNSDirector/PDMR Shareholding
26th Aug 20097:00 amRNSResearch Update
26th Aug 20097:00 amRNSHalf Yearly Report
13th Jul 20097:00 amRNSArk launches Kerraglove woundcare device
1st Jul 20097:00 amRNSRe Agreement
26th Jun 20092:15 pmRNSHolding(s) in Company
24th Jun 20097:00 amRNSManufacturing Update
17th Jun 20097:00 amRNSRe Agreement
3rd Jun 200911:47 amRNSBlocklisting Interim Review
21st May 20097:00 amRNSTrinam Phase III Study Enrols First Patient
18th May 20097:00 amRNSInterim Management Statement
15th May 20097:00 amRNSCerepro Named Patient Supply approved in Finland
13th May 20094:41 pmRNSSecond Price Monitoring Extn
13th May 20094:35 pmRNSPrice Monitoring Extension
12th May 20097:00 amRNSDirector/PDMR Shareholding
6th May 20094:40 pmRNSSecond Price Monitoring Extn
6th May 20094:35 pmRNSPrice Monitoring Extension
5th May 20097:00 amRNSTrinam(R) Awarded Fast Track Status by FDA
30th Apr 20094:01 pmRNSTotal Voting Rights
30th Apr 200912:00 pmRNSPrestigious European Award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.